keyword
https://read.qxmd.com/read/38652826/induction-treatment-for-lupus-nephritis-at-a-high-complexity-hospital-in-chile
#1
JOURNAL ARTICLE
Paulina Ramirez, Andres Giglio, Jorge Verdugo, Francisco Gutierrez
INTRODUCTION: Systemic lupus erythematosus (SLE) causes kidney compromise in up to 40% of patients, contributing significantly to morbidity. Lupus nephritis (LN), an early onset manifestation in most patients, is histologically classified into six types, with types III, IV, and V requiring treatment with induction therapies, usually glucocorticoids with mycophenolate mofetil (MMF) or intravenous cyclophosphamide (IVC). However, up to 60% of patients fail to achieve complete remission, and 27%-66% have subsequent flares...
April 23, 2024: Lupus
https://read.qxmd.com/read/38651106/case-report-chronic-inflammatory-demyelinating-polyneuropathy-superimposed-on-charcot-marie-tooth-type-1a-disease-after-sars-cov-2-vaccination-and-covid-19-infection
#2
Da Li, Hu Yu, Min Zhou, Weinv Fan, Qiongfeng Guan, Li Li
BACKGROUND: There is growing evidence that severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) or COVID-19 infection is associated with the development of immune mediated neuropathies like chronic inflammatory demyelinating polyneuropathy (CIDP), but the impact of SARS-CoV-2 vaccination and COVID-19 infection on genetic disorders such as Charcot-MarieTooth (CMT) remains unclear. CASE PRESENTATION: A 42-year-old male with occulted CMT neuropathy type lA (CMT1A) who developed limb numbness and weakness after the second SARS-CoV-2-vaccination was confirmed by identifying characteristic repeats in the p11...
2024: Frontiers in Neurology
https://read.qxmd.com/read/38648021/interstitial-lung-disease-a-review
#3
JOURNAL ARTICLE
Toby M Maher
IMPORTANCE: Interstitial lung disease (ILD) consists of a group of pulmonary disorders characterized by inflammation and/or fibrosis of the lung parenchyma associated with progressive dyspnea that frequently results in end-stage respiratory failure. In the US, ILD affects approximately 650 000 people and causes approximately 25 000 to 30 000 deaths per year. OBSERVATIONS: The most common forms of ILD are idiopathic pulmonary fibrosis (IPF), which accounts for approximately one-third of all cases of ILD, hypersensitivity pneumonitis, accounting for 15% of ILD cases, and connective tissue disease (CTD), accounting for 25% of ILD cases...
April 22, 2024: JAMA
https://read.qxmd.com/read/38645921/abo-incompatible-renal-transplant-a-single-center-experience-from-india
#4
JOURNAL ARTICLE
Nikita Pawar, Vaibhav Tiwari, Anurag Gupta, Smita Divyaveer, Imran Rather, Shiv Chadha, Vinant Bhargava, Manish Malik, Ashwani Gupta, Anil Kumar Bhalla, D S Rana, Pallav Gupta
INTRODUCTION: In view of ever-increasing end-stage renal disease (ESRD) population but inadequate availability of suitable donors, ABO-incompatible (ABOi) transplantation can be an important void filler. However, at present, ABOi transplantation is limited to a few centers in India and there is a lack of adequate experience and expertise to guide this program to other centers in the country. METHODS: Data of all the ABOi transplants performed from 2012 to 2021 in a tertiary care hospital was retrospectively analyzed...
2024: Indian Journal of Nephrology
https://read.qxmd.com/read/38645919/rituximab-mycophenolate-combination-therapy-in-children-with-calcineurin-inhibitor-resistant-fsgs
#5
JOURNAL ARTICLE
Saumil Gaur, Partha P Paul, Mounika Motamarri
INTRODUCTION: There is a paucity of data and therapeutic options nationally and internationally on calcineurin inhibitor (CNI)-resistant forms of focal segmental glomerulosclerosis (FSGS) in children. CNI (tacrolimus or cyclosporine) are proven monotherapy in children with FSGS with a steroid-dependent (SD) or steroid-resistant (SR) course. We analyzed a novel therapeutic option in CNI-resistant FSGS by using the dual therapy of rituximab and mycophenolate to maintain remission. METHODS: This is a retrospective analysis of clinical, therapeutic profile, and treatment outcomes (sustained remission versus no remission) in subjects with CNI-resistant FSGS who received dual rituximab therapy along with mycophenolate as maintenance therapy for a minimum of 1 year...
2024: Indian Journal of Nephrology
https://read.qxmd.com/read/38644607/a-case-of-immunotherapy-responsive-autoimmune-hemichorea
#6
Rachel E Rodin, Nagagopal Venna, Denis T Balaban
INTRODUCTION: Subacute adult-acquired hemichorea is a striking presentation with a broad differential, including ischemic, metabolic, and inflammatory causes. CASE: We encountered a 74-year-old woman with rapid onset of hemichorea and associated encephalopathy. Following a thorough workup without identification of clear imaging or laboratory abnormalities, we empirically treated with IVIg. Her hemichorea dramatically improved. Due to relapses of hemichorea, she required repeat immunotherapy with IVIg or high dose steroids followed by maintenance mycophenolate...
April 21, 2024: Annals of Clinical and Translational Neurology
https://read.qxmd.com/read/38643544/zhen-wu-tang-ameliorates-lupus-nephritis-by-diminishing-renal-tissue-resident-memory-cd8-t-cells-via-suppressing-il-15-stat3-pathway
#7
JOURNAL ARTICLE
Chun-Ling Liang, Yu-Yan Wei, Yi Chen, Yini Luo, Fenglian Qin, Yuchao Chen, Huazhen Liu, Feifei Qiu, Junbiao Wu, Bin Yang, Yuntao Liu, Zhenhua Dai
Zhen-Wu-Tang (ZWT), a conventional herbal mixture, has been recommended for treating lupus nephritis (LN) in clinic. However, its mechanisms of action remain unknown. Here we aimed to define the immunological mechanisms underlying the effects of ZWT on LN and to determine whether it affects renal tissue-resident memory T (TRM ) cells. Murine LN was induced by a single injection of pristane, while in vitro TRM cells differentiated with IL-15/TGF-β. We found that ZWT or mycophenolate mofetil treatment significantly ameliorated kidney injury in LN mice by decreasing 24-h urine protein, Scr and anti-dsDNA Ab...
April 20, 2024: Biomedicine & Pharmacotherapy
https://read.qxmd.com/read/38641825/characterization-of-the-patterns-of-care-access-and-direct-cost-of-systemic-lupus-erythematosus-in-brazil-findings-from-the-macuna%C3%A3-ma-study
#8
REVIEW
Mirhelen Mendes de Abreu, Odirlei Andre Monticielo, Vander Fernandes, Dalianna Luise Andrade Souto Rodrigues, Cristhiane Almeida Leite da Silva, Alexandre Cristovão Maiorano, Fernando Dos Santos Beserra, Flavia Rachel Moreira Lamarão, Bruna Medeiros Gonçalves de Veras, Nathalie David, Magda Araújo, Marcelly Cristinny Ribeiro Alves, Matheus Amaral Stocco, Fernando Mello Lima, Emilly Borret, Andrese Aline Gasparin, Gustavo Flores Chapacais, Guilherme Andrade Bulbol, Diogo da Silva Lima, Natália Jardim Martins da Silva, Marta Maria Costa Freitas, Blanca Elena Rios Gomes Bica, Domingos Sávio Nunes de Lima, Marta Maria das Chagas Medeiros
BACKGROUND: A cost of illness (COI) study aims to evaluate the socioeconomic burden that an illness imposes on society as a whole. This study aimed to describe the resources used, patterns of care, direct cost, and loss of productivity due to systemic lupus erythematosus (SLE) in Brazil. METHODS: This 12-month, cross-sectional, COI study of patients with SLE (ACR 1997 Classification Criteria) collected data using patient interviews (questionnaires) and medical records, covering: SLE profile, resources used, morbidities, quality of life (12-Item Short Form Survey, SF-12), and loss of productivity...
April 19, 2024: Advances in Rheumatology
https://read.qxmd.com/read/38633948/navigating-treatment-dilemmas-recalcitrant-pemphigus-and-the-burden-of-multiple-comorbidities
#9
Priya Garg, Kshitiz Lakhey, Nishtha Mishra, Yash Buccha, Kirti S Deo
Pemphigus vulgaris is a chronic autoimmune disease of the skin caused by the production of autoantibodies targeting desmogleins 1 and 3 usually presenting in individuals with an average age of onset of approximately 40 years. A 35-year-old obese, diabetic woman presented with fluid-filled lesions over her body for three months along with erosions and painful ulcers in her mouth and genital area for two months. Based on clinical and histopathological studies, the patient was diagnosed as a case of pemphigus vulgaris...
March 2024: Curēus
https://read.qxmd.com/read/38632123/anti-cfh-associated-hemolytic-uremic-syndrome-do-we-still-need-plasma-exchange
#10
JOURNAL ARTICLE
Marion Ferri, Federica Zotta, Roberta Donadelli, Claire Dossier, Charlotte Duneton, Carine El-Sissy, Véronique Fremeau-Bacchi, Thérésa Kwon, Lisa Quadri, Andrea Pasini, Anne-Laure Sellier-Leclerc, Marina Vivarelli, Julien Hogan
BACKGROUND: Between 5 and 50% of atypical hemolytic uremic syndrome (aHUS) cases in children are caused by autoantibodies against complement factor H (CFH). Given the acquired autoimmune nature of the disease, plasma exchange (PE) and various immunosuppressive treatments have been used. More recently, eculizumab has been proposed. METHODS: In this multicenter, retrospective study, we report outcomes of 12 children with anti-FH antibody-associated HUS treated with eculizumab associated with various immunosuppressive regimens...
April 17, 2024: Pediatric Nephrology
https://read.qxmd.com/read/38626662/mycophenolate-and-methotrexate-are-better-tolerated-than-azathioprine-in-myasthenia-gravis
#11
JOURNAL ARTICLE
Katherine C Dodd, Rohan Ahmed, Philip Ambrose, James Kl Holt, Saiju Jacob, M Isabel Leite, James Al Miller, Pyae Phyo San, Jennifer Spillane, Stuart Viegas, Jon Sussman
Azathioprine is recommended as the first-line steroid-sparing immunosuppressive agent for myasthenia gravis. Mycophenolate and methotrexate are often considered as second-line choices despite widespread consensus on their efficacy. We aimed to gather real-world data comparing the tolerability and reasons for discontinuation for these agents, by performing a national United Kingdom survey of side effects and reasons for discontinuation of immunosuppressants in myasthenia gravis. Of 235 patients, 166 had taken azathioprine, 102 mycophenolate, and 40 methotrexate...
March 21, 2024: Neuromuscular Disorders: NMD
https://read.qxmd.com/read/38623524/effective-treatment-of-steroid-resistant-immune-checkpoint-inhibitor-pneumonitis-with-mycophenolate-mofetil
#12
Nao Shioiri, Ryota Kikuchi, Itsuka Matsumoto, Kanako Furukawa, Kenichi Kobayashi, Shinji Abe
Insufficient evidence is available for treating steroid-resistant immune checkpoint inhibitor pneumonitis (CIP). Although guidelines recommend the use of immunosuppressants, the efficacy of mycophenolate mofetil (MMF) has not been sufficiently verified. We report two cases of steroid-resistant CIP treated with MMF. Both patients responded to initial treatment with prednisolone (PSL), but the CIP flared up repeatedly as the steroids were gradually tapered off. Upon receiving MMF in addition to PSL, their subjective symptoms improved, and the shadows gradually disappeared, allowing for a reduction in the steroid dose...
April 2024: Respirology Case Reports
https://read.qxmd.com/read/38621245/pulmonology-what-you-may-have-missed-in-2023
#13
JOURNAL ARTICLE
Aram Karkar, Sana Khan, Rebecca O'Leary, Albina Tyker, Michael Unger
The field of pulmonology saw significant advances in 2023. The publications highlighted in this article address advances and changes in practice related to asthma, chronic obstructive pulmonary disease (COPD), interstitial lung disease, pleural disorders, and sleep-disordered breathing. One article reviews data examining the efficacy of vaccination against respiratory syncytial virus, a respiratory viral illness that has had devastating effects globally. Four studies evaluate the role of various therapies in COPD, including dupilumab, ensifentrine, pulmonary rehabilitation programs, and lung volume reduction versus endobronchial valves...
April 16, 2024: Annals of Internal Medicine
https://read.qxmd.com/read/38615143/post-transplant-cyclophosphamide-calcineurin-inhibitor-and-mycophenolate-mofetil-compared-to-anti-thymocyte-globulin-calcineurin-inhibitor-and-methotrexate-combinations-as-graft-versus-host-disease-prophylaxis-post-allogeneic-stem-cell-transplantation-from
#14
JOURNAL ARTICLE
Arnon Nagler, Myriam Labopin, Ryszard Swoboda, Thomas Schroeder, Rose-Marie Hamladji, Laimonas Griskevicius, Urpu Salmenniemi, Alessandro Rambaldi, Stephan Mielke, Alexander Kulagin, Jakob Passweg, Thomas Luft, Tobias Gedde-Dahl, Edouard Forcade, Grzegorz Helbig, Matthias Stelljes, Cristina Castilla-Llorente, Alexandros Spyridonidis, Eolia Brissot, Fabio Ciceri, Mohamad Mohty
Post-transplant cyclophosphamide plus calcineurin inhibitor (CNI)(tacrolimus or cyclosporine A) plus mycophenolate mofetil (PTCy/TAC or CSA/MMF) and anti-thymocyte globulin plus CNI (tacrolimus or cyclosporine A) plus methotrexate (ATG/TAC or CSA/MTX) are common graft-versus-host disease (GVHD) prophylaxis regimens. We compared the two regimens in patients with acute myeloid leukemia (AML) undergoing allogeneic transplantation from matched siblings or unrelated donors. 402 received PTCy/TAC or CSA/MMF and 5648 received ATG/TAC or CSA/MTX...
April 13, 2024: Bone Marrow Transplantation
https://read.qxmd.com/read/38607424/do-we-really-need-cyclophosphamide-for-lupus-nephritis
#15
JOURNAL ARTICLE
Scott E Wenderfer, Jennifer C Cooper
A 14-year-old patient presents with hematuria and proteinuria. Clinical evaluation reveals a positive anti-nuclear antibody titer, positive anti-double stranded DNA antibody and hypocomplementemia. Systemic lupus erythematosus (SLE) is diagnosed based on the 2019 EULAR/ACR (European League Against Rheumatism/American College of Rheumatology) classification criteria (Aringer et al. Arthritis Rheumatol 71:1400-1412, 2019). A kidney biopsy is performed that confirms the presence of immune complex glomerulonephritis, ISN-RPS (International Society of Nephrology/Renal Pathology Society) class IV (Bajema et al...
April 12, 2024: Pediatric Nephrology
https://read.qxmd.com/read/38603944/acute-rejection-rates-in-vascularized-composite-allografts-a-systematic-review-of-case-reports
#16
REVIEW
Loïc Van Dieren, Pierre Tawa, Marie Coppens, Laura Naenen, Omer Dogan, Tom Quisenaerts, Hyshem H Lancia, Haïzam Oubari, Yohann Dabi, Maxime De Fré, Filip Thiessen Ef, Curtis L Cetrulo, Alexandre G Lellouch
INTRODUCTION: Vascularized Composite Allografts (VCA) are usually performed in a full major histocompatibility complex mismatch setting, with a risk of acute rejection depending on factors such as the type of immunosuppression therapy and the quality of graft preservation. In this systematic review, we present the different immunosuppression protocols used in VCA and point out relationships between acute rejection rates and possible factors that might influence it. METHODS: This systematic review was performed according to the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines...
April 10, 2024: Journal of Surgical Research
https://read.qxmd.com/read/38602169/haploidentical-hematopoietic-stem-cell-transplantation-with-busulfan-cyclophosphamide-and-fludarabine-conditioning-for-x-linked-adrenal-cerebral-leukodystrophy
#17
JOURNAL ARTICLE
Yao Chen, Lan-Ping Xu, Xiao-Hui Zhang, Huan Chen, Kai-Yan Liu, Jiong Qing, Yan-Ling Yang, Xiao-Jun Huang
OBJECTIVE: We investigated the safety and efficacy of haploidentical stem cell transplantation (SCT) in pediatric patients with X-linked adrenoleukodystrophy (ALD). METHODS: A retrospective analysis of transplantation data from 29 cases of ALD, treated between December 2014 and April 2022, was conducted. Neurologic function scores (NFS) were assessed. The conditioning regimen was busulfan 9.6 mg/kg, cyclophosphamide 200 mg/kg, and fludarabine 90 mg/m2 (BFC)...
May 2024: Pediatric Transplantation
https://read.qxmd.com/read/38597437/-jianpi-zishen-granule-inhibits-podocyte-autophagy-in-systemic-lupus-erythematosus-a-network-pharmacology-and-clinical-study
#18
JOURNAL ARTICLE
J Chen, C Huang, M Li
OBJECTIVE: To explore the therapeutic mechanism of Jianpi Zishen (JPZS) granules for systemic lupus erythematosus(SLE) in light of podocyte autophagy regulation. METHODS: TCMSP, GeneCards, OMIM, and TTD databases were used to obtain the targets of JPZS granules, SLE, and podocyte autophagy. The protein-protein interaction network was constructed using Cytoscape, and the key active ingredients and targets were screened for molecular docking. In the clinical study, 46 patients with SLE were randomized into two groups to receive baseline treatment with prednisone acetate and mycophenolate mofetil (control group) and additional treatment with JPZS granules (observation group) for 12 weeks, with 10 healthy volunteers as the healthy control group...
March 20, 2024: Nan Fang Yi Ke da Xue Xue Bao, Journal of Southern Medical University
https://read.qxmd.com/read/38594605/maternal-and-fetal-outcomes-in-pregnancy-complicated-by-pre-existing-lupus-nephritis-insights-from-a-developing-country-pakistan
#19
JOURNAL ARTICLE
Tabassum Elahi, Saima Ahmed, Muhammed Mubarak, Ejaz Ahmed
BACKGROUND: Pregnancy in women with systemic lupus erythematosus (SLE) has remained a great challenge for clinicians in terms of maternal and fetal outcomes. The outcomes in women with pre-existing lupus nephritis (LN) are variable. The impact of different classes of LN on maternal and fetal outcomes during pregnancy is not well defined, as data is very scarce, especially from the developing countries. METHODS: A retrospective analysis was conducted on 52 women with 89 pregnancies...
April 9, 2024: Lupus
https://read.qxmd.com/read/38589827/assessing-antiviral-treatment-efficacy-and-risk-factors-for-severe-covid-19-in-kidney-transplant-recipients-during-the-omicron-subvariant-dominant-period-a-retrospective-study
#20
JOURNAL ARTICLE
Takashi Sakaguchi, Akihiko Mitsuke, Yoichi Osako, Yasutoshi Yamada, Himawari Takeyama, Risako Ogawa, Katsuya Takahashi, Yukiko Hirohata, Sayuri Yamamoto, Junya Arima, Wataru Fukumoto, Satoshi Sugita, Satoru Inoguchi, Ryosuke Matsushita, Hirofumi Yoshino, Shuichi Tatarano, Hideki Enokida
BACKGROUND: Kidney transplant recipients (KTRs) are at risk of severe coronavirus disease 2019 (COVID-19), and even now that Omicron subvariants have become dominant, cases of severe disease are certain to occur. The aims of this retrospective study were to evaluate the efficacy of antiviral treatment for COVID-19 and to identify risk factors for severe disease in KTRs during Omicron subvariant-dominant periods. METHODS: A total of 65 KTRs diagnosed with COVID-19 who received antiviral treatment between July 2022 and September 2023 were analyzed...
April 8, 2024: BMC Nephrology
keyword
keyword
4704
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.